Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Eledon Pharmaceuticals (ELDN) Non Operating Income (2016 - 2026)

Eledon Pharmaceuticals filings provide 3 years of Non Operating Income readings, the most recent being -$5000.0 for Q4 2017.

  • On a quarterly basis, Non Operating Income rose 89.58% to -$5000.0 in Q4 2017 year-over-year; TTM through Dec 2017 was $5000.0, a 101.04% increase, with the full-year FY2024 number at $3.9 million, up 46.75% from a year prior.
  • Non Operating Income hit -$5000.0 in Q4 2017 for Eledon Pharmaceuticals, roughly flat from -$5000.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $53000.0 in Q4 2014 to a low of -$418000.0 in Q3 2016.
  • Median Non Operating Income over the past 3 years was -$5000.0 (2017), compared with a mean of -$49333.3.
  • The widest YoY moves for Non Operating Income: up 105.71% in 2017, down 89.58% in 2017.
  • Eledon Pharmaceuticals' Non Operating Income stood at $53000.0 in 2014, then plummeted by 190.57% to -$48000.0 in 2016, then soared by 89.58% to -$5000.0 in 2017.
  • The last three reported values for Non Operating Income were -$5000.0 (Q4 2017), -$5000.0 (Q3 2017), and $4000.0 (Q2 2017) per Business Quant data.